Normal P50 Suppression in Schizophrenia Patients Treated With Atypical Antipsychotic Medications

OBJECTIVE: Patients with schizophrenia have deficits in attention, cognition, and information processing. Measures such as P50 suppression are used to study cognitive and attentional dysfunction among these patients. P50 suppression is an operational measure of sensory gating that can be assessed by...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of psychiatry 2000-05, Vol.157 (5), p.767-771
Hauptverfasser:	Light, Gregory A., Geyer, Mark A., Clementz, Brett A., Cadenhead, Kristin S., Braff, David L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acoustic Stimulation Adult Antipsychotic Agents - pharmacology Antipsychotic Agents - therapeutic use Antipsychotic drugs Attention Auditory Perception - physiology Benzodiazepines Biological and medical sciences Clozapine - pharmacology Clozapine - therapeutic use Cognition Cognition Disorders - drug therapy Cognition Disorders - psychology Drug therapy Electroencephalography - drug effects Evoked Potentials, Auditory - drug effects Evoked Potentials, Auditory - physiology Female Humans Influences Information processing Male Medical sciences Neuropharmacology Patients Pharmacology. Drug treatments Pirenzepine - analogs & derivatives Pirenzepine - pharmacology Pirenzepine - therapeutic use Psychiatric Status Rating Scales Psychiatry Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology Risperidone - pharmacology Risperidone - therapeutic use Schizophrenia Schizophrenia - diagnosis Schizophrenia - drug therapy Schizophrenic Psychology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!